Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 151 Hifluvac
NCT01008813Phase 2Completed
- Sponsor
- ANRS
- Start
- Oct 2009
- Primary completion
- Feb 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Q-Pan H1N1 in influenza (2 arms), sponsored by ANRS. Primary endpoint: Immunogenicity and safety of A(H1N1)v influenza vaccine at Day 42. Started Oct 2009; status: completed.
02
Drugs
Q-Pan H1N1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01008813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008813.